Uges DR - Search Results

1

Morphine pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates.

Peters JW, Anderson BJ, Simons SH, Uges DR, Tibboel D. Peters JW, et al. Among authors: uges dr. Intensive Care Med. 2005 Feb;31(2):257-63. doi: 10.1007/s00134-004-2545-5. Epub 2005 Jan 28. Intensive Care Med. 2005. PMID: 15678314

2

Morphine metabolite pharmacokinetics during venoarterial extra corporeal membrane oxygenation in neonates.

Peters JW, Anderson BJ, Simons SH, Uges DR, Tibboel D. Peters JW, et al. Among authors: uges dr. Clin Pharmacokinet. 2006;45(7):705-14. doi: 10.2165/00003088-200645070-00005. Clin Pharmacokinet. 2006. PMID: 16802851

3

Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous hemofiltration (CVVH).

van der Werf TS, Mulder PO, Zijlstra JG, Uges DR, Stegeman CA. van der Werf TS, et al. Among authors: uges dr. Intensive Care Med. 1997 Aug;23(8):873-7. doi: 10.1007/s001340050424. Intensive Care Med. 1997. PMID: 9310805 Clinical Trial.

4

Vincristine pharmacokinetics after repetitive dosing in children.

Gidding CE, Meeuwsen-de Boer GJ, Koopmans P, Uges DR, Kamps WA, de Graaf SS. Gidding CE, et al. Among authors: uges dr. Cancer Chemother Pharmacol. 1999;44(3):203-9. doi: 10.1007/s002800050968. Cancer Chemother Pharmacol. 1999. PMID: 10453721 Clinical Trial.

5

Vincristine pharmacokinetics and response to vincristine monotherapy in an up-front window study of the Dutch Childhood Leukaemia Study Group (DCLSG).

Groninger E, Meeuwsen-de Boer T, Koopmans P, Uges D, Sluiter W, Veerman A, Kamps W, de Graaf S. Groninger E, et al. Eur J Cancer. 2005 Jan;41(1):98-103. doi: 10.1016/j.ejca.2004.10.006. Eur J Cancer. 2005. PMID: 15617994

6

Vincristine disposition in children with acute lymphoblastic leukemia.

de Graaf SS, Bloemhof H, Vendrig DE, Uges DR. de Graaf SS, et al. Among authors: uges dr. Med Pediatr Oncol. 1995 Apr;24(4):235-40. doi: 10.1002/mpo.2950240405. Med Pediatr Oncol. 1995. PMID: 7700168

7

Impairment of organ function after oral ingestion of refined petrol.

Janssen S, van der Geest S, Meijer S, Uges DR. Janssen S, et al. Among authors: uges dr. Intensive Care Med. 1988;14(3):238-40. doi: 10.1007/BF00717998. Intensive Care Med. 1988. PMID: 3379185

8

New practical algorithm for modelling retention times in gradient reversed-phase high-performance liquid chromatography.

Hendriks G, Franke JP, Uges DR. Hendriks G, et al. Among authors: uges dr. J Chromatogr A. 2005 Sep 30;1089(1-2):193-202. doi: 10.1016/j.chroma.2005.07.003. J Chromatogr A. 2005. PMID: 16130787

9

Pharmacokinetics of vincristine monotherapy in childhood acute lymphoblastic leukemia.

Groninger E, Meeuwsen-de Boar T, Koopmans P, Uges D, Sluiter W, Veerman A, Kamps W, de Graaf S. Groninger E, et al. Pediatr Res. 2002 Jul;52(1):113-8. doi: 10.1203/00006450-200207000-00021. Pediatr Res. 2002. PMID: 12084857 Clinical Trial.

10

Extensive hepatic replacement due to liver metastases has no effect on 5-fluorouracil pharmacokinetics.

Maring JG, Piersma H, van Dalen A, Groen HJ, Uges DR, De Vries EG. Maring JG, et al. Among authors: uges dr. Cancer Chemother Pharmacol. 2003 Feb;51(2):167-73. doi: 10.1007/s00280-002-0535-2. Epub 2002 Nov 30. Cancer Chemother Pharmacol. 2003. PMID: 12647019

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters